As a sector, agrifood biotech has enormous potential to improve the sustainability, resilience, and productivity of our food systems. Yet many promising innovations still fail to reach the market, often because they are not sufficiently aligned with real-world needs or adoption barriers. The B-Trust project aims to involve end-users from the start, to help make agrifood R&D more relevant, equitable, and impactful.
In December 2025, the European Commission unveiled proposed revisions to the EU’s Medical Device Regulation (MDR) and In Vitro Diagnostic Regulation (IVDR). The changes aim to accelerate the path to market for medtech and digital health companies by making the rulebook easier to navigate without lowering the bar on patient safety. Innovators have greeted the announcement with cautious optimism.
An increasing number of PhD students are concerned about their career prospects. Currently, only around 5-10% of PhD graduates remain in academia — the vast majority have to navigate an unfamiliar job market, where industry demand for their highly educated profiles appears to be in decline. Is a PhD still the best route to professional success? And what can students do to prepare themselves?
Recently at the Medicon Valley Alliance Summit in Copenhagen, the spotlight was on European competitiveness. In a keynote, panelists from four of Europe’s leading life sciences hubs shared their intention to establish a “Champions League” of clusters, working as a team to strengthen health innovation for Europe as a whole.
Biovia is Europe’s first industry-led One Health innovation cluster—uniting medical biotech, medtech, digital health, agtech and industrial biotech to advance human and planetary health. Katrien Lorré explains how this unified approach benefits companies by unlocking opportunities and fostering a better environment for health innovation.
A fresh chapter in Flemish healthtech and life sciences has begun with the launch of Biovia: the health innovation cluster resulting from the merger of flanders.bio and MEDVIA. Unveiled at Knowledge for Growth, the flagship annual conference of the Flemish life sciences sector, this new industry-driven organization brings more than 450 members together in one unified ecosystem – cultivating connections and forging a path to a healthier future for people and planet.
The world is more interconnected than ever. But our global network goes beyond humans: the health of all people on Earth is intimately dependent on the wellbeing of our ecosystems – our animals, plants, microbes, and the atmosphere that sustains us all. In this article, Belgian veterinary scientist Jan Spaas shares his thoughts on the ‘One Health’ approach from the WHO, and the bi-directional link between human and animal health.
Environments are scattered with the DNA of the organisms that inhabit them. Analyzing this DNA could shine a spotlight on how our planet’s biodiversity is changing, from studies in the depths of the oceans to the frigid polar regions. From a One Health perspective, biodiversity is crucial to promoting healthy ecosystems and healthy people.
But, while methods that sequence environmental DNA (eDNA) are increasingly powerful in detecting species without direct observation, we need increasingly powerful algorithms to make sense of the complex DNA world around us to truly protect our planet's biodiversity.
As 2025 comes peeking around the corner, we invite you to look back with us at some of the most exciting science topics we covered this year. From advances in women’s health, organoids, and organ-on-a-chip models to the challenges of data science and innovations in animal science and sustainable biotech; let us walk you through the Benelux life sciences landscape of 2024 as we reflect on the vast amount of knowledge and know-how characteristic to this region.
As a sector, agrifood biotech has enormous potential to improve the sustainability, resilience, and productivity of our food systems. Yet many promising innovations still fail to reach the market, often because they are not sufficiently aligned with real-world needs or adoption barriers. The B-Trust project aims to involve end-users from the start, to help make agrifood R&D more relevant, equitable, and impactful.
In December 2025, the European Commission unveiled proposed revisions to the EU’s Medical Device Regulation (MDR) and In Vitro Diagnostic Regulation (IVDR). The changes aim to accelerate the path to market for medtech and digital health companies by making the rulebook easier to navigate without lowering the bar on patient safety. Innovators have greeted the announcement with cautious optimism.
An increasing number of PhD students are concerned about their career prospects. Currently, only around 5-10% of PhD graduates remain in academia — the vast majority have to navigate an unfamiliar job market, where industry demand for their highly educated profiles appears to be in decline. Is a PhD still the best route to professional success? And what can students do to prepare themselves?
Recently at the Medicon Valley Alliance Summit in Copenhagen, the spotlight was on European competitiveness. In a keynote, panelists from four of Europe’s leading life sciences hubs shared their intention to establish a “Champions League” of clusters, working as a team to strengthen health innovation for Europe as a whole.
Biovia is Europe’s first industry-led One Health innovation cluster—uniting medical biotech, medtech, digital health, agtech and industrial biotech to advance human and planetary health. Katrien Lorré explains how this unified approach benefits companies by unlocking opportunities and fostering a better environment for health innovation.
A fresh chapter in Flemish healthtech and life sciences has begun with the launch of Biovia: the health innovation cluster resulting from the merger of flanders.bio and MEDVIA. Unveiled at Knowledge for Growth, the flagship annual conference of the Flemish life sciences sector, this new industry-driven organization brings more than 450 members together in one unified ecosystem – cultivating connections and forging a path to a healthier future for people and planet.
The world is more interconnected than ever. But our global network goes beyond humans: the health of all people on Earth is intimately dependent on the wellbeing of our ecosystems – our animals, plants, microbes, and the atmosphere that sustains us all. In this article, Belgian veterinary scientist Jan Spaas shares his thoughts on the ‘One Health’ approach from the WHO, and the bi-directional link between human and animal health.
Environments are scattered with the DNA of the organisms that inhabit them. Analyzing this DNA could shine a spotlight on how our planet’s biodiversity is changing, from studies in the depths of the oceans to the frigid polar regions. From a One Health perspective, biodiversity is crucial to promoting healthy ecosystems and healthy people.
But, while methods that sequence environmental DNA (eDNA) are increasingly powerful in detecting species without direct observation, we need increasingly powerful algorithms to make sense of the complex DNA world around us to truly protect our planet's biodiversity.
As 2025 comes peeking around the corner, we invite you to look back with us at some of the most exciting science topics we covered this year. From advances in women’s health, organoids, and organ-on-a-chip models to the challenges of data science and innovations in animal science and sustainable biotech; let us walk you through the Benelux life sciences landscape of 2024 as we reflect on the vast amount of knowledge and know-how characteristic to this region.